• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
AVXL

AVXL

Anavex Life Sciences Corp.

NASDAQHealthcareBiotechnologyUS

USD2.65

-0.14 (-5.03%)

Rating:C

Company Profile

CEO

Christopher U. Missling

IPO Date

2006-08-02

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.73

Prev. Close

$2.79

Day Low

$2.61

Day High

$2.75

52W Low

$2.61

52W High

$13.99

Market Cap

$0.25B

Volume

1.05M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

34.9%

Avg Negative

15.9%

Avg Neutral

49.2%

News Feed

Anavex Life Sciences: Still Room To Run

Seeking Alpha·8/29/2021·↑ positive

Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q3 2021 Results - Earnings Call Transcript

Seeking Alpha·8/12/2021·↓ negative

Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Results

GlobeNewsWire·8/12/2021·↓ negative

Anavex Life Sciences to Participate in the BTIG Virtual Biotechnology Conference 2021

GlobeNewsWire·8/4/2021·↑ positive

Anavex Life's Stock Declines Despite Data Shows Alzheimer's Candidate Prevent Abeta-Induced Cognitive Decline In Animal Study

Benzinga·7/29/2021·↑ positive

Anavex (AVXL) to Report Q3 Earning: What's in the Cards?

Zacks Investment Research·7/27/2021·↑ positive

Why This Anavex Life Sciences Analyst Is Lifting Their Price Target

Benzinga·6/28/2021·↓ negative

AVXL Stock Price Increases Over 15%: Why It Happened

Pulse2·6/28/2021·↑ positive

Anavex Life Sciences Stock Rallies: Technical Levels To Watch

Benzinga·6/28/2021·↑ positive

Why Anavex Life Sciences Shares Are Up 17% Today

The Motley Fool·6/28/2021·↓ negative